Citigroup
RGNX icon

Citigroup’s Regenxbio RGNX Stock Holding History

Citigroup’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$415K Buy
+49,500
New +$520K ﹤0.01% 3651
2025
Q1 		– Sell
-24,900
Closed -$192K – 5896
2024
Q4 		$192K Sell
24,900
-100
-0.4% -$939 ﹤0.01% 4439
2024
Q3 		$262K Buy
+25,000
New +$305K ﹤0.01% 4154
2023
Q4 		– Sell
-50,000
Closed -$823K – 5832
2023
Q3 		$823K Buy
50,000
+25,100
+101% +$455K ﹤0.01% 2670
2023
Q2 		$498K Buy
+24,900
New +$480K ﹤0.01% 3372
2019
Q3 		– Sell
-3,800
Closed -$195K – 7799
2019
Q2 		$195K Sell
3,800
-15,000
-80% -$749K ﹤0.01% 5296
2019
Q1 		$1.08M Sell
18,800
-10,700
-36% -$530K ﹤0.01% 3323
2018
Q4 		$1.24M Buy
+29,500
New +$1.73M ﹤0.01% 3178

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return